Abstract | Recognition of the importance of cell adhesion grew steadily during the twentieth century as it promised answers to fundamental questions in diverse fields that included cell biology, developmental biology, tumorigenesis, immunology and neurobiology. However, the route towards a better understanding of its molecular basis was long and difficult, with many false starts. Major progress was made in the late 1970s to late 1980s with the identification of the major families of adhesion molecules, including integrins and cadherins. This in turn set the stage for the explosive growth in adhesion research over the past 25 years. PERSPECTIVES NATURE REVIEWS | MOLECULAR CELL BIOLOGY VOLUME 13 | DECEMBER 2012 | 805
and a highly influential Gordon Research
Conference heralded the birth of the integ rin family of adhesion receptors. Around this time, other major families of adhesion molecules were also emerging. The dis coveries of these adhesion molecules were the culmination of many decades of effort and, while highly anticipated, the new molecular era in adhesion research that fol lowed greatly exceeded most expectations. It brought unexpected new insights not only into basic cell biology but also into a multitude of fundamental developmental, homeostatic and pathological phenomena. Exciting discoveries continue to this day with no end in sight. We are now beginning to understand how adhesions hold tissues together and generate signals that regulate cell proliferation, survival, migration and gene expression. Through these fundamen tal cellular processes, adhesions mediate tissue formation and regeneration and target immune responses through a highly orches trated interplay among integrins, selectins and the immunoglobulin superfamily of cell adhesion molecules (IgSFCAMs). They also mediate homeostatic mecha nisms such as bone turnover and platelet aggregation. Altered adhesion through receptor s such as integrins and cadherins drive tumour formation, invasion and meta stasis among other pathological processes.
Finally, adhesion figures prominently in efforts to form new tissues either through regeneration or stem cell transplantation, and the role of adhesion in disease may provide routes to the design of diagnostic, prognostic and therapeutic strategies.
This Timeline article outlines some key developments that motivated and moved adhesion research from initial observations to the molecular level. It is written from a personal perspective, which I hope reflects that of many others who entered this field early and led it into the molecular era. I begin with studies that demonstrated the importance of adhesion for holding tissue s and organisms together and implicated adhesion in tissue morphogenesis. Next, I discuss the tissue culture studies that dem onstrated the importance of adhesion in cell growth and sociology and that revealed altered adhesion in cancer cells. Finally, I review the development of approaches used to identify and purify the first cell-cell and cell-substrate adhesion molecules.
Setting the stage
The importance of adhesion emerged around the turn of the twentieth century from multiple sources. Early tissue cultur e studies, initiated by Harrison in 1907, showed convincingly that most tissues were not a syncytium but rather were comprised of individual cells 2 . (FIG. 1) . Furthermore, when dissociated cells from genera of different coloured sponges were mixed, they initially formed mixed genera aggregates but then moved apart, or sorted, to form genusspecific aggregates. These experiments also revealed cell-cell and cell-substratum (matrix) adhesion and the importance of cell migration [5] [6] [7] . Holtfreter moved adhesion research ahead enormously by showing that embry onic tissues could form through adhesion based selforganization 8, 9 . He first observed that dissociated embryonic amphibian tissues can reassociate to recapitulate their initial morphology. He also found that gas trula layers can be dissociated into single cells by high pH and then reassociate and organize to recapitulate the early embryonic layers when the pH is reduced. Thus, the notion emerged that tissues can selforganize by sorting out individual cells through dif ferential adhesion with other cells. Moscona generalized this to other organisms by showin g that tissues can be dissociated using a b trypsin, and this led to many dissociation and reaggregation studies using different vertebrate species and tissues 10, 11 . From these findings, the hypothesis arose and soon dominated models of morpho genesis that tissues are formed through the migration and sorting of cells with different adhesive properties.
Tyler, Weiss and Sperry began to place this concept on a molecular footing. Tyler and Weiss proposed that the adhesion between cells arises from an antibodyantigenlike interaction between cell surface molecules 12, 13 . Consistent with this, Spiegel showed that antibodies against the surfaces of both sponges and amphibian embryos inhibited the reaggregation of dissociated cells in a cell type and speciesdependent manner, respectively 14, 15 . On the basis of studies in the 1940s of neural regeneration, Sperry proposed the chemoaffinity (also known as chemospecificity) hypothesis 16, 17 . He suggested that neural connections arise in part through the recognition of "identification tags" and that each axon becomes selectively attached to specific neurons depending on "specific chemical affinities" 17 . Interest in adhesion also came from studies of disease. Analyses of squamous cell carcinomas showed decreased cell-cell adhesion forces and implicated adhesion in invasion and metastasis 18 . Studies in the 1950s and 1960s using fibroblast cell lines and their viral transformants as a model for tumorigenic transformation also observed changes at the cell surface and in cell adhesion during tumorigenesis 19 . Whereas normal cells required anchor age to a substratum for growth, some viral transformants did not 20 . Furthermore, transformed fibroblasts often did not show the densitydependent inhibition of growth seen in untransformed fibroblasts 21 . They also showed an abnormal morphology, migrated faster and did not exhibit 'con tact inhibition' of movement (that is, the local inhibitio n of movement observed when normal cells contact each other and stops them from 'walking' over each other); this loss of contact inhibition was implicated in tumour invasion 22, 23 . The idea that the cell surface changed during transformation was also supported by changes in both the agglutin ation response to plant lectins and the carbohydrates that were present on the cell surface 24, 25 . All of this fuelled much speculation about the molecular basis of adhesion and the need to identify the implicated adhesion molecules. At the same time, this early work provided novel quantitative techniques (such as Moscona's dissociation-reaggregatio n system and the quantification of cell attach ment to dishes) and powerful strategies for the identification of these putative adhe sion molecules. The early focus was on agglutinin s and cell surface carbohydrates, either acting directly via a carbohydrate 'code' or through a lectinlike binding pro tein or glycosyltransferases 26 . But, despite a diversity of approaches and strategies to identify molecules that stimulate or inhibit adhesion, progress was slow.
Cell-cell adhesion molecules CsA and NCAM. The Tyler-Weiss hypo thesis and Spiegel's observations led Gerisch to raise antisera against adhesioncompetent (aggregating) Dictyostelium discoideum cells, which acquire this phenotype during their transition from a growth phase to a multi cellular slug. Using the monovalent antibodies (Fab fragments) that were not adsorbed by aggregationincompetent (growth phase) cells, an antigen, contact site A (csA) protein, was purified and shown to mediate adhesion 27, 28 . Edelman and coworkers adapted and refined this strategy (FIG. 2) to isolate a neural cell adhesion molecule (NCAM) 29 . Fabʹ frag ments from antibodies raised against embry onic retinal cells inhibited the reaggregation of the embryonic tissues. Proteins in culture supernatants were fractionated biochemi cally and assayed for their ability to block the adhesioninhibiting activity of the antibodies. The active protein fraction was then used to prepare a new antiserum, and Fab frag ments from this were used to immunopurify the 140 kDa NCAM cell surface adhesion molecule. The transient, localized expression of NCAM during central nervous system (CNS) development suggested that it has a major role in this process 30 . NCAM is now viewed as one of many adhesion molecules that mediate nervous system development.
Cadherins.
The earliest studies of cell separation and reaggregation pointed to a c alciumdependent cell adhesion mecha nism. Using a lung cell line from Chinese hamsters, Takeichi showed that cell-cell interactions were mediated by calcium dependent and calciumindependent systems. Both mechanisms were inhib ited by trypsin. However, if calcium was present, trypsin no longer inhibited the calciumdependent system, and calcium also inhibited the release of certain cell sur face components 31, 32 . This observation led to an experimental strategy, based on the approach used by Gerisch and Edelman, and allowed the identification of a 134 kDa cell surface component and a 34 kDa proteolytic fragment that were responsible for cell-cell adhesion in F9 terato carcinoma cells 33 . The calciumdependent adhesion propertie s of this molecul e led to the name 'cadherin' . Introduction of its cDNA into L cells induced calciummediate d adhesion 34 . Edelman had previously identified a 124 kDa protein that mediated adhesion of chicken hepatocytes 35 . Others, using related cell adhesion systems, such as mouse embryo compaction 36, 37 and a mammary carcinoma 38 , also identified 34 kDa, 80 kDa and 130 kDa molecules that were implicated in cell-cell adhesion. We now know that these molecules are all related and form the cadherin protein family 39 . Each of these cad herins was characterized as having different tissue distribution and adhesion specificities. These proteins include: Ncadherin, which is expressed in the brain and mesenchyme; Ecadherin, which is expressed in epithelia; Pcadherin, which is expressed in the pla centa; and VEcadherin, which is expressed in the endothelium. Cadherinmediated adhesions, like those mediated by NCAM, are homophilic interactions. 
ECM
The discovery of the protocadherins expanded the cadherins into a very large superfamily of adhesion molecules 40, 41 . Within this family, the classic cadherin s regulate cytoskeletal associations via catenins, which were discovered in coi mmunoprecipitation studies with Ecadherin 42 . They link to actin filaments via αcatenin-vinculi n 43 and regulate WNT signalling through βcatenin 44 . Classic cadherins mediate cell rearrangements that result in the formation of tissues, for exam ple tubule and ductal morphogenesis in epithelia and gastrulation during develop ment 45 , and they regulate barrier function in epithelia and endothelia 45 . It is now clear that some cadherins are sensitive to local forces such as shear stress in endothelial cells 46 . Ncadherin has a tissuespecific role in synapse formation and brain morpho genesis, and there is also a plethora of proto cadherins, which may contribute to synaptic specificity in the brain 47 . Finally, cadherins are strongly implicated in tumorigenesis, partly through effects on epithelialto mesenchyma l transition 48 . Subsequently, other cell-cell adhesion families emerged, including: lectin cell adhesion molecules (LECCAMs; for exam ple selectins), which mediate lymphocyte homing and leukocyte-endothelial inter actions 49, 50 ; and IgSFCAMs, which mediate various cell-cell interactions 51 . IgSFCAMs include intercellular adhesion molecule 1 (ICAM1) and vascular cell adhesion pro tein (VCAM), which are also involved in leukocyt e-endothelial interactions, as well as NCAM.
Cell-matrix adhesion molecules
Meanwhile, a search was also ongoing for cell-substrate adhesion molecules, but the path to their discovery was different. As cell culture became more widely used in the 1960s and early 1970s, particularly to study cancer and cell differentiation, the impor tance of cell-substrate adhesion became increasingly evident. Whereas untrans formed cells would grow only when adhered to a substratum, this limiting property was lost in many cancer cells. Furthermore, specific matrix components, and even their physical nature, were implicated in the in vitro differentiation of muscle cells 52 , hepatocytes 53 and mammary epithelial cells 54, 55 . Cell culture also opened the door to new quantitative microscopy methods to study the morphologies and migration of individual cells, the subcellular localization of specific molecules that they expressed and the changes in these properties that were observed in transformed cells. These methods greatly facilitated the search for the molecular mediators of cell-matrix adhesion.
Identification of focal adhesions. Two major discoveries moved this quest ahead dramatically. First, interference reflection microscopy revealed that adhesions are Figure 2 | Experimental strategies that allowed the identification of adhesion molecules. a | The isolation of neural cell adhesion molecule (NCAM) using antibody purification. Embryonic retinal cells were dissociated using trypsin and then allowed to reaggregate. Fabʹ fragments from antibodies raised against retinal cells bound to the cells and prevented their reaggregation. Proteins released into tissue culture supernatants were fractionated and assayed for fractions that relieved this antibody inhibition. Immunization against the active protein fraction then allowed the isolation of a highly specific blocking antibody that was used to purify the 140 kDa antigen as NCAM 29 . b | The isolation of integrins using monoclonal antibodies. After immunizing mice with embryonic muscle cells, hybridomas were prepared and cloned. The supernatants from single cell lines were then assayed for those that inhibit the adhesion of embryonic skeletal muscle cells to the substratum. The active monoclonal antibodies were then used for immunolocalization and immunoprecipitation, which led to the isolation of β1 integrins 68, 69 . c | Isolation of a fibronectin receptor. The identification of a specific adhesion-binding motif, RGDS, from fibronectin provided the means for an affinity purification strategy. A large cell adhesion-promoting chymotryptic fragment from fibronectin was conjugated onto an affinity column support, which would retain binding proteins upon the addition of a cell extract. Addition of Arg-Gly-Asp-Ser (RGDS) but not Arg-Gly-Glu-Ser (RGES) peptides eluted a specific membrane protein that, when isolated and reconstitute d in liposomes, mediated binding to fibronecti n 74, 75 . ECM, extracellular matrix. discrete focal regions of close contact with the tissue culture substratum and thereby provided an easy localizationbased assay for cell-substrat e adhesion molecules 56, 57 . The combined use of interference reflection and electron microscopy showed that these adhesions were sites where actin filament bundles terminate 57, 58 . Second, the molecu lar era was accelerated by the discovery that molecules such as actin could be removed from SDS-PAGE gels and used to raise anti bodies for immunolocalization 59 . Using this method, antibodies were generated against chicken gizzard smooth muscle αactinin and shown to distribute along actin fila ment bundles and in the (adhesion) plaques observed at the ends of the bundles 60 . Vinculin 61 and talin 62 were then identified as new molecules that localize specifically in adhesion plaques (FIG. 3) . These studies founded the molecular era of cell-matrix adhesion research, although all of the mol ecules identified with this approach resided on the cytoplasmic face of the membrane.
Fibronectin is a matrix adhesion molecule.
Independently, a search for cell surface molecules that changed during cell trans formation revealed the secreted matrix component fibronectin as a large exter nal t ransformationsensitive protein (LETS) 63 . When fibronectin was added back to cultures of virally transformed cells, these cells reverted to a normal phenotype: cell-substrat e adhesion increased; the cells assumed a flatter morphology; and contact inhibition of movement was restored 64 . Fibronectin resided in cell-substrate adhe sions and also coaligned with actin filament bundles 65 . This showed that cells were adher ing to a specific matrix protein rather than to the tissue culture substratum. It also pointed to the presence of transmembrane molecules that link actin filaments and fibronectin and mediate cell adhesion to fibronectin.
Integrins. The identification of cell-matrix adhesion receptors was achieved using both biochemical and immunological techniques. Affinity chromatography using matrix components such as fibronectin domi nated the biochemical approach, whereas antibodies that inhibit adhesion formed the basis for the immunological approach. In retrospect, however, the low affinity of the receptor for its ligand, the large number of binding domains on extracellular matrix (ECM) components such as fibronectin, the presence of multiple related receptors and the heterodimeric nature of the recep tors impeded progress. As a result, mixtures of proteins, often in the 140 kDa range 66 , were purified rather than the single protein seen in purifications of cell-cell adhesion components.
It was the development of monoclonal antibodies that moved the field forward. With them it was possible to produce, in vitro, individual cell lines secretin g an antibody that recognized a single epitope 67 . A monoclonal antibody that inhibits substratum adhesion could then be used for 'one step' affinity purifica tion and immuno fluorescence (FIG. 2b) . Two monoclonal antibodies were isolated that inhibited adhesion of embryonic skeletal muscle. They bound a complex in the 140 kDa range that localized along actin filament bundles and in adhesions and also dissociated embryo explants into single cells [68] [69] [70] [71] . The complex also bound to fibronectin and talin, which is an actin associated cytoplasmic protein that binds vinculin 72 . cDNA cloning of one subunit (the βsubunit) revealed a transmembrane domain and thus fit the role of the trans membrane linker proposed previously 72, 73 . This subunit was named integrin to reflect its integral membrane protein nature and its role in linking the cytoskeleton and fibronectin. The name also presaged the integrative nature of integrins in cell signal ling 73 . The biochemical problem of assaying putative membrane receptors for binding to large multidomain matrix proteins was aided by the identification of a peptide sequence, ArgGlyAspSer (RGDS), in fibronectin that mediates cell adhesion 74 . This major discovery also led to an affinity approach for identifying a 140 kDa receptor comple x for fibronecti n 75 (FIG. 2c) .
Membrane protein complexes with simi lar molecular weights were also emerging in other contexts. For example, a monoclonal antibody raised against T cells revealed a complex that inhibited T cell function by blocking cell-cell adhesion between the killer T cell and its target cell 76 . The antibody precipitated a small set of hetero dimeric lymphocyte receptors (leukocyte functionassociated antigen 1 (LFA1), macro phage 1 antigen (MAC1), P150,95) that share a common subunit and are involved in adhesionrelated processes 77 , and a mutation in the common subunit leads to leukocyte adhesion deficiency 78, 79 . Another group of monoclonal antibodie s (VLA1-5) was raised that recognized antigens appearing very late after T cell activation, and the heterodimeric receptors that they recognized also shared a com mon subunit 80 . In addition, a pair of cell surface proteins present on platelets were shown to be greatly reduced in patients with Glanzmann thrombasthenia 81, 82 , a platelet aggregation defect, and these proteins were identified as receptors for several RGD containing molecules including fibrinogen and fibronectin 83, 84 . Finally, Drosophila melanogaster positionspecific antigens, which showed varying expression through out development, were also characterized as a heterodimeric complex of glycoproteins that shared a common subunit 85 . All these findings came together in 1986 to 1987. Several common properties, includ ing molecular weight similarities, sequence homology by cDNA and partial peptide analyses and antibody crossreactivity, revealed that these receptors were related heterodimeric complexes 1, 86 . Families were defined by common βsubunits, and the different specificities within a family were dictated by the αsubunit. In 1987, Hynes organized a key Gordon Research Conference (FIG. 4) and wrote a pivotal review that brought this family together and named it the integrins 1 , the name assigned previously to the β1 subunit that defined matrix adhesion receptors 73 . The identifica tion of this large family brought together people from various fields of research including immunology, cancer, vascular biology, cell biology and development. It created the integrin field as we now know it
. The result was an enor mous synergy; each integrin had its own story, and when conjoined with the others, research leapt ahead. At the same time, other adhesion families including cadherins, selectins (LECCAMs) and IgSFCAMs were also emerging.
The large range of ECM ligands and cell surface receptors implied that integrins comprised a major adhesion system not only for cell-matrix adhesion but also for cell-cell adhesion. Moreover, knockout and mutant mouse studies began to reveal integrin functions that spanned from devel opment to death in many cell types and organisms 87 . It soon became clear that inte grins not only hold cells together but also initiate and organize signalling networks that regulate proliferation, gene expression, migration and cell survival. In this respect, integrin adhesions function like growth fac tor receptors with which they synergize 88 . The emergence of the specific signals that are generated from integrin signalling, the complexes and posttranslational events that regulate integrins and the mechanisms by which integrins on resting platelets and leukocytes become activated were character ized in great detail and reviewed in a previous perspective article 89 . The con formational changes in integrins that drive their activation and their regulation are now understood in exquisite detail 90 . These signalling networks established a molecular framework for understanding some of the phenomena, such as anchorage dependent growth, that originally motivated the search for cell-matrix receptors. For some cellular processes such as migration and gene expression, the role of adhesion was unexpectedly complex. In migrating cells, for example, adhesions not only form the traction points by which cells move, but they also generate the transient, local signals that regulate compartmentalized processes that drive migration such as pro trusion, contraction, front-back polarity and even adhesion 91 . The forces on adhesions, through a poorly understood signalling loop, in turn, regulate these signals. They also regulate gene expression and explain the early observations that epithelial cells, for example, develop better on compliant substrates 92, 93 . The many downstream effects that integrin signalling can have and the complex nature of its regulation remain a challenge for understanding how adhesions affect different cellular processes.
A bright outlook
Breathtaking progress has been made over the past 25 years; however, much still remains to be learned, and some of the questions that originally motivated adhesion research have not been answered. For exam ple, synaptic specificity and the mechanism of tissue morphogenesis and regeneration are complex and not understood. Although the role of adhesion in diseases such as cancer, thrombosis, cardiovascular disease and inflammation is being addressed, only a handful of therapeutics has emerged so far, and the potential of adhesion research for diagnostics, prognostics and therapeutics has not been fully exploited. Finally, the dominant role proposed for cell surface carbohydrates in adhesive specificity still remains unclear 26 . The cell biology of adhesion also faces major challenges. The mechanism by which physical forces and local pliability regulate adhesion and the signals they produce is not understood. Nonetheless, pliability is a crucial component of the cellular micro environment and determines cell function, and this is a particularly pressing issue in tumour biology 94 . The structure of the supramolecular assemblies that comprise adhesions and how these structures vary among different adhesions and in response to the local environment are also not known. Recent advances in superresolution microscopy and multiscale structural analyses that combine nuclear magnetic resonance (NMR), Xray crystallography, tomography and light microscopy are only just beginning to unravel these mysteries 95 . Although optical methods, reagents and analytic tools are being developed that can localize, measure and correlate cellu lar activities, measure intra and extra cellular forces (biosensors) and perturb these activities using photoactivating and photoinhibiting reagents, the repertoire needs to be expanded and extended to cells in vivo. Finally, all that we have learned about adhesion will need to be translated to complex activities and diseases at the organismal level.
When I became interested in adhesion as a graduate student in the late 1960s, adhe sion research had great promise for a young biophysicist looking for a career trajectory. However, I did not anticipate the extent to which it would exceed my already enor mous expectations. I also did not foresee the embracing and open nature of the adhesion community. Watching this field mature from description to molecule to mechanism has been exhilarating, and all of us who have contributed to the field have had a wonderful ride.
Box 1 | Recollections from the adhesion community
Richard Hynes "The convergence of multiple fields -cancer, development, haemostasis, immunology -and phyla (vertebrates, insects) where people had found receptors mediating different functions was very exciting as it became clear that there was a family of related genes/proteins. The different fields had different questions and different insights -cell migration, cell-matrix adhesion, cell-cell adhesion, activatable receptors, patterning in embryos. This meant that each field acquired new ways of thinking about the functions of their receptors and could feed off the insights of the other fields. That meeting nucleated a field with common goals and the culture of sharing of ideas and reagents was enormously fruitful in subsequent years." (regarding the 1987 Gordon Research Conference).
Mark Ginsberg
"As a Physician-Scientist, the integrin field provided me with validation of the critical role of basic science in new therapies; it is a classic 'bedside to bench and back again' story. Basic studies of Glanzmann Thrombasthenia and Leukocyte Adhesion Deficiency, recessive diseases due to mutations affecting β3 or β2 integrins, respectively, were instrumental in the discovery of the integrin family, elucidation of mechanisms of ligand binding and activation of integrins, and in assignment of integrin functions in humans. This basic research provided the essential foundation and impetus for the development of integrin-targeted therapeutics for diseases such as heart attack, stroke, and multiple sclerosis."
Masatoshi Takeichi "I recall that integrin and cadherin were cloned in similar years (1986 for integrin and 1987 for E-cadherin). Thus, the studies of cell-substrate and cell-cell adhesion advanced in parallel -both complementing and synergizing with each other. Thanks to this lucky history, we could quickly establish a clear, definite, and more complete picture of cell adhesion." Kenneth M. Yamada "Once integrins were identified, our hopes that complicated biology could be explained by specific protein-protein interactions came true, both for receptor-type binding at the cell surface and aggregates of cytoskeletal and signalling proteins inside cells. What was surprising, however, was the broad importance of integrins to so many different kinds of signalling."
